Cerba Research is your premier destination for preclinical research services, specializing in virology and immunology. As a leading NIH (National Institutes of Health) approved CRO and clinical trial specialty lab and operation services company, we offer a comprehensive range of preclinical services aimed at testing the safety, effectiveness, pathogenicity, and pharmacokinetics (PK) of various therapeutics such as antivirals, immunomodulators, drugs, antibodies, and vaccines designed to combat infectious diseases.
With an extensive track record in the field, we possess the expertise to work with a multitude of viral targets, including Influenza, HSV, RSV, hMPV, MERS Coronavirus, SARS-CoV, SARS-CoV-2, Varicella Zoster Virus, Measles Virus, Dengue Virus, Monkeypox Virus, Rabies Virus, Polio Virus, Parainfluenza, Highly Pathogenic Avian Influenza, and more. Our versatile preclinical animal models, which encompass mice, cotton rats, ferrets, hamsters, rabbits, and more, allow us to tailor our services to your specific research needs.
What We Can Offer in Preclinical Services
Our highly skilled professionals offer (Pre) Clinical Test Services for Vaccines, Anti Virals and Immunomodulators
- Vaccine efficacy
- Antiviral efficacy
- Non-clinical efficacy (Animal Rule)
- Model development
- Customized models (Immune Suppression)
- Board Certified Pathologist
- Full Pathology (inc. Immunostains)
- In vitro compounding screening
- Preclinical sample testing
- In vitro / ex vivo models for early-stage efficacy testing (3Rs)
Assays for Preclinical Services
At Cerba Research, we are dedicated to advancing virology research by developing innovative models to monitor therapeutic efficacy and the emergence of antiviral resistance. Our in-house team of experts is continually working on the development of models that can be applied to various viral, bacterial, and oncological targets, including viral vectors for gene therapy.
We offer a broad array of read-outs, covering virus titers, virus copies, antibodies, genomics, pathology, histopathology, clinical signs, imaging, and more. Our assays can be customized to meet your specific requirements, adhering to the principles of the 3 Rs (Replacement, Reduction, and Refinement) to ensure ethical and responsible preclinical research practices.
Our Pre-clinical Laboratories:
BSL2 and BSL3 laboratories
Basic cell culture, Virus culture (ML2 and ML3), Molecular virology, Serology and Histological pre-processing
Quality Assurance and Regulatory Compliance
Delivering reliable and high-quality data is our utmost priority. Cerba Research Laboratory has adopted a high-quality standard in all operations, testing procedures and reporting. The quality management system is based on NEN-EN-ISO 15189, GLP, GCLP, GSLP, and expanded with elements of GCP, to comply with regulatory requirements and facilitate regulatory submissions. Our commitment to quality ensures that your research findings are robust, reliable, and ready for further development.
Cerba Research is your trusted partner in preclinical research services, ready to support your endeavors in the fight against infectious diseases and the development of life-saving therapies.
State-Of-The-Art Containment Facilities
Our BSL-2 and BSL-3 facilities allow for complicated experiments with extremely pathogenic viruses, promoting the development of research techniques to study highly prevalent diseases such as COVID-19.
The combination of our highly advanced BSL2 and BSL3 animal facilities with our highly qualified scientists generates successful study outcomes for extremely effective preclinical services.
We promote simple micro-management methods and give a clear overview of results. By working with fewer vendors, services are easy to navigate and give you access to detailed evidence for your research.
Reach out to our experts and see how we can help advance your clinical trialContact Us